AA-Feno-Super · DIN 02246860 · 160 mg · tablet
General benefitMarketed · checked November 19, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
AA-Feno-Super · DIN 02246860
Manufacturer: A A Pharma Inc.; listing date 2006-06-14
Health Canada: Marketed since 2021-09-24 · brand AA-FENO-SUPER · ATC C10AB05 FENOFIBRATE · form Tablet · route Oral · ingredients FENOFIBRATE 160 MG · company Aa pharma inc · schedule Prescription
AA-Feno-Super: Formulary list price $1.00 per unit (the source does not state the unit; exact figure $1.0022). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02246860)
Source record
DIN 02246860: AA-Feno-Super
Raw flags: chronicUseMed=Y, sec3=Y
Item: 240600043; group id 303; item number 0661; lccId None; manufacturer id AAP
Source form: Tab; strength: 160mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $1.0022; ministry $1.0022
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02246860
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71083
Interchangeable products
Lipidil Supra · DIN 02241602 · $1.0022
Shortage status: not checked (no credentials)